Cargando…

Physical function in children/adolescents with chronic kidney disease and the impact of exercise intervention: a protocol for systematic review and meta-analysis

INTRODUCTION: Impaired physical function is relatively common in children/adolescents with chronic kidney disease (CKD), affecting not only patients’ daily lives but also the efficiency of later treatment and rehabilitation. Exercise is a recognised intervention to improve physical function and qual...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qiuzi, Huang, Liuyan, Wang, Hui, Zhang, Huachun, Zhang, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582871/
https://www.ncbi.nlm.nih.gov/pubmed/37848265
http://dx.doi.org/10.1136/bmjpo-2023-002151
Descripción
Sumario:INTRODUCTION: Impaired physical function is relatively common in children/adolescents with chronic kidney disease (CKD), affecting not only patients’ daily lives but also the efficiency of later treatment and rehabilitation. Exercise is a recognised intervention to improve physical function and quality of life in adult patients with CKD. However, implementing this strategy in paediatric/adolescent populations remains relatively limited. For exercise training to be widely delivered as part of paediatric public health policy, a better understanding of the physical function and the impact of exercise interventions in children/adolescents with CKD is needed. METHODS AND ANALYSIS: A systematic review and meta-analysis will be conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to compare physical function in children/adolescents with CKD with healthy controls and the impact of exercise interventions on their outcomes. The systematic review will search the following databases: PubMed, Embase, Scopus and Web of Science. We will use the Risk Of Bias In Non-Randomised Studies-of Interventions and the second edition of the Cochrane Risk of Bias to assess the quality of the literature. Where feasible, we will conduct random effects meta-analyses where appropriate. If possible, we will conduct subgroup analyses to explore potential sources of heterogeneity. ETHICS AND DISSEMINATION: Due to the nature of the protocol, ethical approval is not required. We will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to disseminate the study results through publication and conference presentations. PROSPERO REGISTRATIONNUMBER: CRD42023416208.